| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
21,040,000 |
| Market
Cap: |
987.20(M) |
| Last
Volume: |
55,338 |
Avg
Vol: |
95,423 |
| 52
Week Range: |
$41.52 - $67.92 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Related Products |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ INDUSTRIAL |
|
S&P SMALLCAP 600 |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile USANA Health Sciences develops and manufactures science-based nutritional, personal care and skincare products. Co.'s principal product lines include: USANA® Nutritionals Optimizers, which consists of targeted supplements designed to meet individual health and nutritional needs; Essentials/CellSentials®, which includes primary vitamin and mineral supplements that provide a foundation of body nutrition for every age group with children 13 months of age; Foods, which includes meal replacement shakes, snack bars, and other related products that provide macro-nutrition in various formats; and Personal Care and Skincare, which includes its science-based personal care products and Celavive.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
48,133 |
48,445 |
65,028 |
143,144 |
| Total Sell Value |
$2,296,962 |
$2,312,477 |
$3,371,359 |
$8,352,397 |
| Total People Sold |
12 |
12 |
14 |
16 |
| Total Sell Transactions |
14 |
15 |
26 |
50 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sinnott Robert A |
Chief Scientific Officer |
• – – |
2020-04-24 |
4 |
S |
$83.00 |
$238,542 |
D/D |
(2,874) |
0 |
|
7% |
|
| Fuller Gilbert A |
Director |
– • – |
2020-04-24 |
4 |
S |
$83.86 |
$27,590 |
D/D |
(329) |
0 |
|
7% |
|
| Winssinger Frederic J |
Director |
– • – |
2020-04-23 |
4 |
S |
$82.45 |
$90,607 |
D/D |
(1,099) |
500 |
|
4% |
|
| Foukas Joshua |
Chief Legal Officer |
• – – |
2020-04-23 |
4 |
S |
$82.49 |
$162,169 |
D/D |
(1,966) |
0 |
|
4% |
|
| Auciaux Robert |
Director |
– • – |
2020-03-31 |
4 |
D |
$57.76 |
$5,718 |
D/D |
(99) |
691 |
|
- |
|
| Auciaux Robert |
Director |
– • – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
790 |
|
- |
|
| Fuller Gilbert A |
Director |
– • – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
329 |
|
- |
|
| Pelosi Peggie |
Director |
– • – |
2020-03-31 |
4 |
D |
$57.76 |
$8,837 |
D/D |
(153) |
853 |
|
- |
|
| Pelosi Peggie |
Director |
– • – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
1,006 |
|
- |
|
| Winssinger Frederic J |
Director |
– • – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
1,599 |
|
- |
|
| Peng Feng |
Director |
– • – |
2020-03-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
329 |
1,599 |
|
- |
|
| Guest Kevin |
C.E.O. |
• – – |
2020-02-10 |
4 |
S |
$81.00 |
$615,276 |
D/D |
(7,596) |
12,691 |
|
6% |
|
| Guest Kevin |
C.E.O. |
• – – |
2020-02-10 |
4 |
OE |
$70.75 |
$537,379 |
D/D |
7,596 |
20,287 |
|
- |
|
| Mulham David Mulham |
Chief Sales Officer |
• – – |
2020-02-10 |
4 |
S |
$81.00 |
$307,638 |
D/D |
(3,798) |
8,239 |
|
6% |
|
| Mulham David Mulham |
Chief Sales Officer |
• – – |
2020-02-10 |
4 |
OE |
$70.75 |
$268,690 |
D/D |
3,798 |
12,037 |
|
- |
|
| Brown Jim |
President |
• – – |
2020-02-10 |
4 |
S |
$80.50 |
$157,458 |
D/D |
(1,956) |
8,095 |
|
6% |
|
| Brown Jim |
President |
• – – |
2020-02-10 |
4 |
OE |
$70.75 |
$138,377 |
D/D |
1,956 |
10,051 |
|
- |
|
| Jones Paul A. |
Chief Leadership Dev Officer |
• – – |
2020-02-10 |
4 |
S |
$81.00 |
$264,465 |
D/D |
(3,265) |
5,034 |
|
6% |
|
| Jones Paul A. |
Chief Leadership Dev Officer |
• – – |
2020-02-10 |
4 |
OE |
$70.75 |
$230,982 |
D/D |
3,265 |
8,299 |
|
- |
|
| Iiekking G Doug |
CFO |
• – – |
2020-02-10 |
4 |
S |
$83.44 |
$188,501 |
D/D |
(2,259) |
0 |
|
6% |
|
| Peng Feng |
Director |
– • – |
2020-02-07 |
4 |
S |
$80.96 |
$22,829 |
D/D |
(282) |
1,270 |
|
2% |
|
| Brown Jim |
President |
• – – |
2020-02-07 |
4 |
S |
$81.00 |
$142,074 |
D/D |
(1,754) |
8,095 |
|
2% |
|
| Brown Jim |
President |
• – – |
2020-02-07 |
4 |
OE |
$70.75 |
$124,087 |
D/D |
1,754 |
9,849 |
|
- |
|
| Jones Paul A. |
Chief Leadership Dev Officer |
• – – |
2020-02-07 |
4 |
S |
$80.50 |
$335,791 |
D/D |
(4,168) |
5,034 |
|
2% |
|
| Jones Paul A. |
Chief Leadership Dev Officer |
• – – |
2020-02-07 |
4 |
OE |
$70.75 |
$294,865 |
D/D |
4,168 |
5,567 |
|
- |
|
2039 Records found
|
|
Page 26 of 82 |
|
|
0.21 (0.45%) 
